Your session is about to expire
← Back to Search
Smaller Diaphragm Monitoring Catheter for Premature Infants with Respiratory Distress
Study Summary
This trial will test a new, smaller tube to help very premature babies who are on NAVA ventilation. The new tube is 4 mm instead of 6 mm, with all other parameters the same. The study will use 10 babies who are already receiving NAVA ventilation.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a known genetic or chromosomal condition.I do not have any current severe infections or serious bowel and lung conditions.Babies who are not stable from breathing or heart perspectives, as decided by the doctor.My newborn weighs less than 1000g and is on NAVA ventilation.
- Group 1: NVR 4mm Edi Catheter
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there open slots available for enrolment in this trial?
"Clinicaltrials.gov indicates that this trial is actively seeking participants as of now, with the first post being made on October 1st 2022 and a recent update occurring on September 26th 2022."
How many people have enrolled in this research initiative?
"Affirmative. Information on clinicaltrials.gov supports the active recruitment of this medical experiment, which was published on October 1st 2022 and revised as recently as September 26th 2022. In total, 10 participants are required from a single site."
Share this study with friends
Copy Link
Messenger